Abstract:Objective The justification for magnetic resonance imaging (MRI) in isolated mild ventriculomegaly remains controversial. This study was undertaken to evaluate the contribution of third-trimester MRI in isolated 10-to 12-mm fetal ventriculomegaly.Design Observational prospective cohort study.Setting Universitary prenatal reference centre.Population From February 2000 to May 2005, we prospectively collected data concerning fetuses referred to us for cerebral MRI following detection of ventriculomegaly by ultras… Show more
“…Early work by Garel and Alberti 17 seemed to support that assumption, but a more recent publication, including the same author, showed the opposite conclusion. 18 The retrospective analysis of Salomon et al 18 included 185 thirdtrimester fetuses who had isolated mild VM (ie, 10-to 12-mm trigones) as measured on sonography. They found that the most frequent disagreement between sonography and iuMR was in the classification of the degree of VM.…”
BACKGROUND AND PURPOSE:Fetal ventriculomegaly (VM) is important because of its high prevalence and high risk of association with other brain abnormalities. The purpose of this article was to investigate the hypotheses that including in utero MR imaging (iuMR) in the diagnostic pathway for fetuses with isolated VM on antenatal imaging will show other brain abnormalities in a high proportion of cases and that these will have a significant effect on clinical management.
“…Early work by Garel and Alberti 17 seemed to support that assumption, but a more recent publication, including the same author, showed the opposite conclusion. 18 The retrospective analysis of Salomon et al 18 included 185 thirdtrimester fetuses who had isolated mild VM (ie, 10-to 12-mm trigones) as measured on sonography. They found that the most frequent disagreement between sonography and iuMR was in the classification of the degree of VM.…”
BACKGROUND AND PURPOSE:Fetal ventriculomegaly (VM) is important because of its high prevalence and high risk of association with other brain abnormalities. The purpose of this article was to investigate the hypotheses that including in utero MR imaging (iuMR) in the diagnostic pathway for fetuses with isolated VM on antenatal imaging will show other brain abnormalities in a high proportion of cases and that these will have a significant effect on clinical management.
“…The value of in utero MRI in cases of ultrasound diagnosed fetal isolated VM is addressed by a number of recent studies (Malinger et al, 2004;Valsky et al, 2004;Ouahba et al, 2006;Salomon et al, 2006;Benacerraf et al, 2007;Glenn and Barkovich, 2006a;Glenn and Barkovich, 2006b;Morris et al, 2007). The percentage of additional abnormalities diagnosed by MRI ranges from 5% (Salomon et al, 2006) to 50% (Morris et al, 2007).…”
Section: Structural Malformationsmentioning
confidence: 99%
“…VM is severe when the measurement of the ventricular width is >15 mm, or ≥15 mm according to different authors (Den Hollander et al, 1998;Graham et al, 2001;Gaglioti et al, 2005;Breeze et al, 2007); it is defined mild or borderline when the measurement is less (Wax et al, 2003;Wyldes and Watkinson, 2004). Recent data would suggest to further divide borderline VM into mild (10-12 mm) and moderate (>12-15 mm) (Signorelli et al, 2004;Gaglioti et al, 2005;Salomon et al, 2006;Falip et al, 2007).…”
Section: Prenatal Definitionsmentioning
confidence: 99%
“…The value of in utero MRI in cases of ultrasound diagnosed fetal isolated VM is addressed by a number of recent studies (Malinger et al, 2004;Valsky et al, 2004;Ouahba et al, 2006;Salomon et al, 2006;Benacerraf et al, 2007;Glenn and Barkovich, 2006a;Glenn and Barkovich, 2006b;Morris et al, 2007). The percentage of additional abnormalities diagnosed by MRI ranges from 5% (Salomon et al, 2006) to 50% (Morris et al, 2007). Such large differences among studies could be due to the variable standards of ultrasound or MRI, but could also be explained by the type of malformations observed; in fact, it seems that MRI is superior to ultrasound in detecting parenchymal damage, migrational abnormalities, infarctions, germinal matrix hemorrhage and intraventricular hemorrhage, but not other malformations for which a dedicated neurosonographic examination could be superior (Malinger et al, 2004).…”
Fetal cerebral ventriculomegaly (VM) is diagnosed when the width of one or both ventricles, measured at the level of the glomus of the choroid plexus (atrium), is ≥10 mm. VM can result from different processes: abnormal turnover of the cerebrospinal fluid (CSF), neuronal migration disorders, and destructive processes. In a high percentage of cases, it is associated with structural malformations of the central nervous system (CNS), but also of other organs and systems. The rate of associated malformations is higher (≥60%) in severe VM (>15 mm) and lower (10-50%) in cases of borderline VM (10-15 mm). When malformations are not present, aneuploidies are found in 3-15% of borderline VM; the percentage is lower in severe VM. The neurodevelopmental outcome of isolated VM is normal in >90% of cases if the measurement of ventricular width is between 10 and 12 mm; it is less favorable when the measurement is >12 mm.
“…The use of magnetic resonance imaging (MRI) has been advocated as a useful tool in evaluating fetuses with mild VM [2,19,22,26]; it adds important information in 6%-10% of the cases, particularly in recognizing associated cortical anomalies. For this reason the appropriate time to perform MRI is in the third trimester; it must be done by experienced operators in reference centers, following an accurate neurosonography in order to avoid useless request of such a sophisticated and expansive procedure.…”
Section: Ruling Out For Associated Anomaliesmentioning
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.